Overview

Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital

Status:
Withdrawn

Trial end date:
2012-09-01

Target enrollment:

Participant gender:

Summary

The study will assess the use of paliperidone palmitate compared with oral antipsychotic treatment in delaying time to a protocol-defined treatment failure over 12 months, in patients diagnosed with schizophrenia who were recently released from an inpatient psychiatric hospital.

Phase:

Phase 4

Details

Lead Sponsor:

Ortho-McNeil Janssen Scientific Affairs, LLC

Treatments:

Antipsychotic Agents
Aripiprazole
Olanzapine
Paliperidone Palmitate
Perphenazine
Quetiapine Fumarate
Risperidone